DBVT Stock Analysis: Buy, Sell, or Hold?

DBVT - DBV Technologies S.A.

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$19.65
-0.19 (-0.96%) ▼
5d: -0.41%
30d: -4.66%
90d: -5.98%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: Apr 29, 2026 0d

Get Alerted When DBVT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: DBVT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: DBVT is currently trading at $19.65, which is considered slightly low relative to its 30-day fair value range of $19.61 to $21.08.

Technical Outlook: Technically, DBVT is showing sideways momentum. Immediate support is located at $18.92, while resistance sits at $20.92.

Market Sentiment: DBVT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $40.58 (+106.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position SLIGHTLY LOW
Historical Trading Range $19.61 - $21.08
Company Quality Score 53/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 57.9%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 106.5% below Wall St target ($40.58)

Trading Range Analysis

30-Day Trading Range $19.61 - $21.08
Current vs Trading Range SLIGHTLY LOW

Support & Resistance Levels

Support Level $18.92
Resistance Level $20.92
Current Trend Sideways
Technical data as of May 15, 2026

Fundamental Context

Forward P/E (Next Year Est.) -46.86
Wall Street Target $40.58 (+106.5%)
Revenue Growth (YoY) 12.5%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: May 18, 2026 9:06 AM ET
Data refreshes hourly during market hours. Next update: 10:06 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Pharis Mohideen SELL 534 shares 2026-01-29
Bpifrance Epic SELL 1292103 shares 2025-12-18
Bpifrance Epic SELL 2076990 shares 2025-12-17

Unlock Insider Activity

See real-time buying/selling by company executives for DBVT.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ACLX
Arcellx Inc
STRONG BUY
18 analysts
$113 57 HOLD
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 57 HOLD
BBIO
BridgeBio Pharma Inc
STRONG BUY
19 analysts
$103 55 HOLD
BNTX
BioNTech SE
STRONG BUY
21 analysts
$126 48 HOLD
GPCR
Structure Therapeutics I…
STRONG BUY
14 analysts
$106 56 HOLD

More Analysis for DBVT

DBVT Technical Chart DBVT Price Prediction DBVT Earnings Date DBVT Investment Advisor DBVT Fair Price Analyzer DBVT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals